Clinical trial NCT04568564: Telerehabilitation in Lung Surgery Patients
Official title: Telerehabilitation of Reduced Physiotherapy Service in SARS-CoV-2 Pandemic Process in Lung Surgery Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Lung Cancer
Physiotherapy
Keywords: exercise
videoconference
lung cancer
surgery
postoperative
chest physiotherapy
telerehabilitation
Lead sponsor: Istanbul Medipol University Hospital
Sponsor class: OTHER
First posted: 2020-09-29
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Randomized controlled trial
Primary purpose: SUPPORTIVE_CARE

Brief summary: In this study, providing access to physiotherapy applications by telerehabilitation method and the effectiveness of this application will be examined for patients who have undergone lung surgery in the early postoperative period during the pandemic process in which social isolation continues.

Detailed description: * Patients who meet the inclusion criteria and agree to participate in the study will be included in the study.
* Patients diagnosed with lung cancer and underwent thoracotomy will be randomly divided into Telerehabilitation Group (TGR) and Control (KG) groups.
* Before the operation, enlightened and signed consent will be obtained from the cases, the first evaluations of the patients in both groups will be made and the first exercise training will be given to the telerehabilitation group.
* The study group will be followed up every day during their hospitalizations and the final tests of both groups will be made before discharge. Long-term follow-up will be carried out in the 1st month and 3rd month after discharge.

Eligibility criteria: Inclusion Criteria:

* Having a smart phone and capable of making video calls,
* Planned to be operated with thoracotomy or videothoracoscope,
* Staged between IA and IIIB with clinical staging,
* With proven lung tumor (If AC diagnosis is not confirmed after frozen or wedge, the patient will be excluded from the study),
* Patients with no cardiac disease (ASA II or better) that affects their quality of life.

Exclusion Criteria:

* Having a cardiac disease that affects the quality of life,
* Serious cognitive problems and presence of psychiatric diseases,
* Presence of physical limitations (vision, hearing impairment, orthopedic problems).

Primary outcomes:
measure: Major complication rate
timeFrame: Up to 3 months
Secondary outcomes:
measure: The six-minute walking test
timeFrame: Up to 3 months
measure: Modified Medical Research Council Dyspnea Scale
timeFrame: Up to 3 months
measure: Visual analog scale
timeFrame: Up to 3 months
measure: Duration of tube thoracostomy drainage
timeFrame: Up to 3 months
measure: Forced expiratory volume one second (FEV1)
timeFrame: Up to 3 months
measure: Forced vital capacity (FVC)
timeFrame: Up to 3 months
measure: Diffusion Capacity
timeFrame: Change from baseline to 1 and 3 months
measure: Lung Capacities
timeFrame: Change from baseline to 1 and 3 months
measure: Lung V/Q Scintigraphy
timeFrame: Change from baseline to 1 and 3 months
measure: Procalcitonin (PCT)
timeFrame: Up to 3 months
measure: C-Reactive Protein (CRP)
timeFrame: Up to 3 months
measure: Ferritin
timeFrame: Up to 3 months
measure: Lactate dehydrogenase
timeFrame: Up to 3 months
measure: D'dimer test
timeFrame: Up to 3 months
measure: Partial Carbon monoxide Pressure (PaCO2)
timeFrame: Up to 3 months
measure: Partial Oxigen Pressure (PaO2)
timeFrame: Up to 3 months
measure: Arterial blood oxygen saturation level (SaO2)
timeFrame: Up to 3 months
measure: Anxiety inventory
timeFrame: Up to 3 months
Other outcomes:
Locations:
city: İstanbul
country: Turkey
facility: Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine Thoracic Surgery Clinic
Study officials:
References: